{"result": {"id": "173b4d19-2198-4ae4-ba6a-ee42831f4b98", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "(\"entity\"<|>CLINICAL PHARMACOLOGY & THERAPEUTICS<|>ORGANIZATION<|>Clinical Pharmacology & Therapeutics is a journal published by Wiley Periodicals LLC on behalf of the American Society for Clinical Pharmacology and Therapeutics, where the study was published.)  \n##\n(\"entity\"<|>BERT LANGUAGE MODEL<|>ORGANIZATION<|>The BERT language model is a natural language processing tool used in the study to analyze and cluster sentences from EPARs.)  \n##\n(\"entity\"<|>UNIFORM MANIFOLD APPROXIMATION AND PROJECTION<|>ORGANIZATION<|>Uniform Manifold Approximation and Projection (UMAP) is a dimensionality reduction technique used in the study to process data from EPARs.)  \n##\n(\"entity\"<|>DENSITY-BASED SPATIAL CLUSTERING OF APPLICATIONS WITH NOISE<|>ORGANIZATION<|>Density-Based Spatial Clustering of Applications with Noise (DBSCAN) is a clustering algorithm used in the study to group sentences from EPARs based on semantic similarities.)  \n##\n(\"relationship\"<|>EUROPEAN MEDICINES AGENCY<|>CLINICAL PHARMACOLOGY & THERAPEUTICS<|>The EMA's study on EPARs was published in Clinical Pharmacology & Therapeutics<|>6)  \n##\n(\"relationship\"<|>BERT LANGUAGE MODEL<|>UNIFORM MANIFOLD APPROXIMATION AND PROJECTION<|>The BERT language model was used in conjunction with UMAP for dimensionality reduction in the study<|>8)  \n##\n(\"relationship\"<|>UNIFORM MANIFOLD APPROXIMATION AND PROJECTION<|>DENSITY-BASED SPATIAL CLUSTERING OF APPLICATIONS WITH NOISE<|>UMAP and DBSCAN were used together in the study to cluster sentences from EPARs<|>8)  \n##\n(\"relationship\"<|>BERT LANGUAGE MODEL<|>DENSITY-BASED SPATIAL CLUSTERING OF APPLICATIONS WITH NOISE<|>The BERT language model and DBSCAN were used together to analyze and cluster sentences from EPARs<|>8)  \n<|COMPLETE|>", "refusal": null, "role": "assistant", "audio": null, "function_call": null, "tool_calls": null}}], "created": 1737091649, "model": "deepseek-chat", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_3a5770e1b4", "usage": {"completion_tokens": 475, "prompt_tokens": 2694, "total_tokens": 3169, "completion_tokens_details": null, "prompt_tokens_details": null, "prompt_cache_hit_tokens": 2176, "prompt_cache_miss_tokens": 518}}, "input": {"messages": [{"content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: Within the European Union, the European Medicines Agency's (EMA's) European Public Assessment Report (EPAR) is an important source of information for healthcare professionals and patients that allows them to understand important risks and uncertainties associated with the use of a medicine. However, the EPAR sections describing such important uncertainties can differ substantially in wording, length, and detail, thereby potentially limiting understanding. In this study, we therefore present a natural language processing approach to cluster sentences extracted from the sections on uncertainties in EPARs of centrally authorized medicines, as a steppingstone to harmonization of text describing uncertainties. We used a BERT language model together with dimensionality reduction (Uniform Manifold Approximation and Projection (UMAP)) and clustering (Density-Based Spatial Clustering of Applications with Noise (DBSCAN)) to identify semantic similarities between sentences. Clusters were labeled according to an overarching topic by reviewing the semantically similar sentences. Each cluster was also characterized according to medicine-related characteristics, such as efficacy or side effects. In total, 1,648 medicines were included in this study. For 573 of these medicines (authorized July 27, 2010 to December 31, 2022), we identified an EPAR that described a complete regulatory dossier and contained sections on uncertainties. Of these, 553 EPARs could be attributed to unique active substance-indication combinations. In these 553 EPARs, we identified 13,105 sentences in sections on uncertainties, leading to 26 clusters of which 2 were labeled as noise. The clusters and associated topics provided in this article can be used by regulators and medicine developers as a steppingstone toward a unified way of communicating uncertainties identified during the EMA process to the broader public. Â© 2024 The Authors. Clinical Pharmacology & Therapeutics published by Wiley Periodicals LLC on behalf of American Society for Clinical Pharmacology and Therapeutics.\n######################\nOutput:", "role": "user"}, {"role": "assistant", "content": "(\"entity\"<|>EUROPEAN MEDICINES AGENCY<|>ORGANIZATION<|>The European Medicines Agency (EMA) is a regulatory body within the European Union responsible for the evaluation and supervision of medicinal products. It produces the European Public Assessment Report (EPAR), which provides information on the risks and uncertainties associated with medicines.)  \n##\n(\"entity\"<|>EUROPEAN PUBLIC ASSESSMENT REPORT<|>EVENT<|>The European Public Assessment Report (EPAR) is a document produced by the EMA that provides detailed information on the risks, uncertainties, and benefits of medicines authorized for use in the European Union.)  \n##\n(\"entity\"<|>WILEY PERIODICALS LLC<|>ORGANIZATION<|>Wiley Periodicals LLC is a publishing company that published the article in which this study was presented, on behalf of the American Society for Clinical Pharmacology and Therapeutics.)  \n##\n(\"entity\"<|>AMERICAN SOCIETY FOR CLINICAL PHARMACOLOGY AND THERAPEUTICS<|>ORGANIZATION<|>The American Society for Clinical Pharmacology and Therapeutics is a professional organization focused on advancing the field of clinical pharmacology and therapeutics. It is associated with the publication of the study in Clinical Pharmacology & Therapeutics.)  \n##\n(\"entity\"<|>EUROPEAN UNION<|>GEO<|>The European Union is a political and economic union of member states in Europe, within which the EMA operates to regulate medicines.)  \n##\n(\"relationship\"<|>EUROPEAN MEDICINES AGENCY<|>EUROPEAN PUBLIC ASSESSMENT REPORT<|>The EMA produces the EPAR to provide information on medicines<|>9)  \n##\n(\"relationship\"<|>EUROPEAN MEDICINES AGENCY<|>EUROPEAN UNION<|>The EMA operates within the regulatory framework of the European Union<|>8)  \n##\n(\"relationship\"<|>WILEY PERIODICALS LLC<|>AMERICAN SOCIETY FOR CLINICAL PHARMACOLOGY AND THERAPEUTICS<|>Wiley Periodicals LLC published the study on behalf of the American Society for Clinical Pharmacology and Therapeutics<|>7)  \n<|COMPLETE|>"}, {"content": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "role": "user"}], "parameters": {"model": "deepseek-chat", "frequency_penalty": 0.0, "max_tokens": 4000, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0}}}